BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 28838188)

  • 21. Safety and immunogenicity of a pentavalent diphtheria, tetanus, pertussis, hepatitis B and polio combination vaccine in infants.
    Yeh SH; Ward JI; Partridge S; Marcy SM; Lee H; Jing J; Curry ES; Howe BJ
    Pediatr Infect Dis J; 2001 Oct; 20(10):973-80. PubMed ID: 11642632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of a significant interaction between a Haemophilus influenzae conjugate vaccine combined with a diphtheria toxoid, tetanus toxoid and acellular pertussis vaccine in the same syringe and inactivated polio vaccine.
    Daum RS; Zenko CE; Given GZ; Ballanco GA; Parikh H; Vidor E; Liu X
    Pediatr Infect Dis J; 2000 Aug; 19(8):710-7. PubMed ID: 10959738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Communications, Immunization, and Polio Vaccines: Lessons From a Global Perspective on Generating Political Will, Informing Decision-Making and Planning, and Engaging Local Support.
    Menning L; Garg G; Pokharel D; Thrush E; Farrell M; Kodio FK; Veira CL; Wanyoike S; Malik S; Patel M; Rosenbauer O
    J Infect Dis; 2017 Jul; 216(suppl_1):S24-S32. PubMed ID: 28838189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Introduction of inactivated poliovirus vaccine leading into the polio eradication endgame strategic plan; Hangzhou, China, 2010-2014.
    Liu Y; Wang J; Liu S; Du J; Wang L; Gu W; Xu Y; Zuo S; Xu E; An Z
    Vaccine; 2017 Mar; 35(9):1281-1286. PubMed ID: 28161421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel).
    Johns TL; Hutter GE
    Ann Pharmacother; 2010 Mar; 44(3):515-23. PubMed ID: 20197476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acceptance of the Administration of Multiple Injectable Vaccines in a Single Immunization Visit in Albania.
    Preza I; Subaiya S; Harris JB; Ehlman DC; Wannemuehler K; Wallace AS; Huseynov S; Hyde TB; Nelaj E; Bino S; Hampton LM
    J Infect Dis; 2017 Jul; 216(suppl_1):S146-S151. PubMed ID: 28838166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.
    Li R; Li CG; Li Y; Liu Y; Zhao H; Chen X; Kuriyakose S; Van Der Meeren O; Hardt K; Hezareh M; Roy-Ghanta S
    Vaccine; 2016 Mar; 34(12):1436-43. PubMed ID: 26873055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
    Orenstein WA;
    Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
    O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
    Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polio vaccines: WHO position paper, March 2016-recommendations.
    World Health Organization
    Vaccine; 2017 Mar; 35(9):1197-1199. PubMed ID: 27894720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib).
    Martinón-Torres F; Boisnard F; Thomas S; Sadorge C; Borrow R;
    Vaccine; 2017 Jun; 35(30):3764-3772. PubMed ID: 28583305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. National introduction of fractional-dose inactivated polio vaccine in Sri Lanka following the global "switch".
    Gamage D; Ginige S; Palihawadana P
    WHO South East Asia J Public Health; 2018 Sep; 7(2):79-83. PubMed ID: 30136665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introduction of Inactivated Polio Vaccine, Withdrawal of Type 2 Oral Polio Vaccine, and Routine Immunization Strengthening in the Eastern Mediterranean Region.
    Fahmy K; Hampton LM; Langar H; Patel M; Mir T; Soloman C; Hasman A; Yusuf N; Teleb N
    J Infect Dis; 2017 Jul; 216(suppl_1):S86-S93. PubMed ID: 28838199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety profile of
    Puente Gómez I; Verheust C; Hanssens L; Dolhain J
    Expert Rev Vaccines; 2020 Aug; 19(8):771-779. PubMed ID: 32729745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the reactogenicity of three different immunization schedules including diphtheria, tetanus, pertussis, Haemophilus influenza b and polio vaccine in Turkey.
    Beyazova U; Yüksel N; Aksakal FN; Camurdan AD
    Trans R Soc Trop Med Hyg; 2013 Jul; 107(7):438-43. PubMed ID: 23720155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, dose-ranging assessment of the immunogenicity and safety of a booster dose of a combined diphtheria-tetanus-whole cell pertussis-hepatitis B-inactivated poliovirus-Hemophilus influenzae type b (DTPw-HBV-IPV/Hib) vaccine vs. co-administration of DTPw-HBV/Hib and IPV vaccines in 12 to 24 months old Filipino toddlers.
    Quiambao B; Van Der Meeren O; Kolhe D; Gatchalian S
    Hum Vaccin Immunother; 2012 Mar; 8(3):347-54. PubMed ID: 22330958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The challenge of changing the inactivated poliomyelitis vaccine in Latin America: declaration of the Latin American Society of Pediatric Infectious Diseases (SLIPE).
    Falleiros-Arlant LH; Avila-Agüero ML; Brea del Castillo J; Mariño C
    Rev Chilena Infectol; 2014 Oct; 31(5):590-603. PubMed ID: 25491459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Introduction of Inactivated Poliovirus Vaccine in National Immunization Program and Polio Endgame Strategy.
    ; Vashishtha VM; Choudhary J; Yadav S; Unni JC; Jog P; Kamath SS; Sachdeva A; Srirampur S; Prajapati B; Parekh BJ
    Indian Pediatr; 2016 Aug; 53 Suppl 1():S65-S69. PubMed ID: 27133231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coverage estimates and patterns of inactivated poliovirus vaccine (IPV) use prior to and during the polio eradication endgame, Jinan City, China, 2010-2015.
    Chang C; Zhang J; Zhou J; Cao R; Song K; Liu C; Zhang X; Geng X; Liu X; Li C
    Hum Vaccin Immunother; 2016 Nov; 12(11):2749-2752. PubMed ID: 27437792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of immune interference between inactivated polio vaccine and inactivated rotavirus vaccine co-administered by intramuscular injection in two animal species.
    Wang Y; Zade J; Moon SS; Weldon W; Pisal SS; Glass RI; Dhere RM; Jiang B
    Vaccine; 2019 Jan; 37(5):698-704. PubMed ID: 30626530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.